Microgynon Fe, one of the most widely used oral contraceptive globally is now available in Nigerian pharmacies following the recent launch of the product at Sheraton Hotels, Abuja. The product comes as a result of an innovative public-private partnership between Bayer HealthCare and the United States Agency for International Development (USAID).
The partnership is designed to make more affordable family planning choices available to women through the private sector and address the growing demand for contraceptives and the overall sustainability of supply. Family planning allows couples to plan their families as they desire, reduces the risks from unintended and/or high-risk pregnancies, and improves the health of mothers and their children by allowing time between pregnancies.
READ ASLO Why Rumours Trail Account Pitches- Centerspread COO
After the introduction of Microgynon Fe in Ethiopia, Uganda, Tanzania, Malawi, Rwanda, Ghana, Nigeria and Kenya, the Bayer-USAID partnership plans to expand the initiative to several more Sub-Saharan countries by 2016. USAID Nigeria’s Director, Health, Population and Nutrition office, Dr. Nancy Lawenthal, emphasized the importance of public-private partnerships in helping governments meet their Millennium Development Goals (MDGs).
“We are pleased that this important initiative between USAID and Bayer Healthcare is being extended to Nigeria. The private sector has an important role to play in contributing to sustainable development and in this case, by ensuring that Nigerian women have access to a sustainable supply of quality, affordable oral contraceptives.”
Microgynon Fe is manufactured in Germany by Bayer HealthCare and imported to Nigeria by CHI Pharmaceuticals.